Global Nonalcoholic Steatohepatitis (NASH) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

ID:PD031677
November 2020
GIR (Global Info Research)

Single User License: $ 3480.00 Multi User License: $ 5220.00 Enterprise License: $ 6960.00

Description
Table Of Content

The Global Nonalcoholic Steatohepatitis (NASH) Market Report is equipped with market data from 2015 to 2025. The report gives a covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2020 to 2025. The detailed sales channel is also covered in the study.

The global Nonalcoholic Steatohepatitis (NASH) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 44.7% in the forecast period of 2020 to 2025 and will expected to reach USD 9415.5 million by 2025, from USD 2147 million in 2019.

The Nonalcoholic Steatohepatitis (NASH) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nonalcoholic Steatohepatitis (NASH) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nonalcoholic Steatohepatitis (NASH) market has been segmented into:

Obeticholic acid（OCA）
Selonsertib
Emricasan
GR-MD-02
IMM-124E

By Application, Nonalcoholic Steatohepatitis (NASH) has been segmented into:

Hospital Pharmacy
Online Provider
Retail Pharmacy

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nonalcoholic Steatohepatitis (NASH) market presented in the report. This section sheds light on the sales growth of different regional and country-level Nonalcoholic Steatohepatitis (NASH) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nonalcoholic Steatohepatitis (NASH) market.

The report offers in-depth assessment of the growth and other aspects of the Nonalcoholic Steatohepatitis (NASH) market in important countries (regions), including:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Nonalcoholic Steatohepatitis (NASH) Market Share Analysis
Nonalcoholic Steatohepatitis (NASH) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nonalcoholic Steatohepatitis (NASH) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nonalcoholic Steatohepatitis (NASH) sales, revenue and market share for each player covered in this report.

The major players covered in Nonalcoholic Steatohepatitis (NASH) are:

Tobira Therapeutics
Intercept Pharmaceuticals
Galmed Pharmaceuticals
Cadila Healthcare
Gilead Sciences
Conatus Pharmaceuticals
Takeda
Genfit
Gemphire Therapeutics
Novartis International

There are 14 Chapters to deeply display the Global Nonalcoholic Steatohepatitis (NASH) market.
1 Nonalcoholic Steatohepatitis (NASH) Market Overview
2 Company Profiles
3 Market Competition by Players
4 Market Size by Regions
5 North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
6 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
7 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
8 South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
9 Middle East & Africa Revenue Nonalcoholic Steatohepatitis (NASH) by Countries
10 Market Size Segment by Type
11 Global Nonalcoholic Steatohepatitis (NASH) Market Segment by Application
12 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix

Table of Contents

1 Nonalcoholic Steatohepatitis (NASH) Market Overview
    1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
    1.2 Classification of Nonalcoholic Steatohepatitis (NASH) by Type
        1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Type
        1.2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Type in 2019
        1.2.3 Obeticholic acid（OCA）
        1.2.4 Selonsertib
        1.2.5 Emricasan
        1.2.6 GR-MD-02
        1.2.7 IMM-124E
    1.3 Global Nonalcoholic Steatohepatitis (NASH) Market by Application
        1.3.1 Overview: Global Nonalcoholic Steatohepatitis (NASH) Revenue by Application
        1.3.2 Hospital Pharmacy
        1.3.3 Online Provider
        1.3.4 Retail Pharmacy
    1.4 Global Nonalcoholic Steatohepatitis (NASH) Market by Regions
        1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions
        1.4.2 Global Market Size of Nonalcoholic Steatohepatitis (NASH) (2015-2025)
        1.4.3 North America (USA, Canada and Mexico) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2015-2025)
        1.4.4 Europe (Germany, France, UK, Russia and Italy) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2015-2025)
        1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2015-2025)
        1.4.6 South America (Brazil, Argentina, Colombia) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2015-2025)
        1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2015-2025)
2 Company Profiles
    2.1 Tobira Therapeutics
        2.1.1 Tobira Therapeutics Details
        2.1.2 Tobira Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
        2.1.3 Tobira Therapeutics SWOT Analysis
        2.1.4 Tobira Therapeutics Product and Services
        2.1.5 Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.2 Intercept Pharmaceuticals
        2.2.1 Intercept Pharmaceuticals Details
        2.2.2 Intercept Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.2.3 Intercept Pharmaceuticals SWOT Analysis
        2.2.4 Intercept Pharmaceuticals Product and Services
        2.2.5 Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.3 Galmed Pharmaceuticals
        2.3.1 Galmed Pharmaceuticals Details
        2.3.2 Galmed Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.3.3 Galmed Pharmaceuticals SWOT Analysis
        2.3.4 Galmed Pharmaceuticals Product and Services
        2.3.5 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.4 Cadila Healthcare
        2.4.1 Cadila Healthcare Details
        2.4.2 Cadila Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
        2.4.3 Cadila Healthcare SWOT Analysis
        2.4.4 Cadila Healthcare Product and Services
        2.4.5 Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.5 Gilead Sciences
        2.5.1 Gilead Sciences Details
        2.5.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
        2.5.3 Gilead Sciences SWOT Analysis
        2.5.4 Gilead Sciences Product and Services
        2.5.5 Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.6 Conatus Pharmaceuticals
        2.6.1 Conatus Pharmaceuticals Details
        2.6.2 Conatus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.6.3 Conatus Pharmaceuticals SWOT Analysis
        2.6.4 Conatus Pharmaceuticals Product and Services
        2.6.5 Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.7 Takeda
        2.7.1 Takeda Details
        2.7.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
        2.7.3 Takeda SWOT Analysis
        2.7.4 Takeda Product and Services
        2.7.5 Takeda Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.8 Genfit
        2.8.1 Genfit Details
        2.8.2 Genfit Major Business and Total Revenue (Financial Highlights) Analysis
        2.8.3 Genfit SWOT Analysis
        2.8.4 Genfit Product and Services
        2.8.5 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.9 Gemphire Therapeutics
        2.9.1 Gemphire Therapeutics Details
        2.9.2 Gemphire Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
        2.9.3 Gemphire Therapeutics SWOT Analysis
        2.9.4 Gemphire Therapeutics Product and Services
        2.9.5 Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
    2.10 Novartis International
        2.10.1 Novartis International Details
        2.10.2 Novartis International Major Business and Total Revenue (Financial Highlights) Analysis
        2.10.3 Novartis International SWOT Analysis
        2.10.4 Novartis International Product and Services
        2.10.5 Novartis International Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
    3.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Players (2015-2020)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Nonalcoholic Steatohepatitis (NASH) Players Market Share
        3.2.2 Top 10 Nonalcoholic Steatohepatitis (NASH) Players Market Share
    3.3 Market Competition Trend
4 Market Size by Regions
    4.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Regions
    4.2 North America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    4.3 Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    4.4 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    4.5 South America Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    4.6 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
5 North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
    5.1 North America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2015-2020)
    5.2 USA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    5.3 Canada Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    5.4 Mexico Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
6 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
    6.1 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2015-2020)
    6.2 Germany Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    6.3 UK Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    6.4 France Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    6.5 Russia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    6.6 Italy Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
    7.1 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2015-2020)
    7.2 China Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    7.3 Japan Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    7.4 Korea Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    7.5 India Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    7.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
8 South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries
    8.1 South America Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2015-2020)
    8.2 Brazil Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    8.3 Argentina Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nonalcoholic Steatohepatitis (NASH) by Countries
    9.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2015-2020)
    9.2 Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    9.3 UAE Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    9.4 Egypt Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
    9.5 South Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
    10.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2015-2020)
    10.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Type (2019-2024)
    10.3 Obeticholic acid（OCA） Revenue Growth Rate (2015-2025)
    10.4 Selonsertib Revenue Growth Rate (2015-2025)
    10.5 Emricasan Revenue Growth Rate (2015-2025)
    10.6 GR-MD-02 Revenue Growth Rate (2015-2025)
    10.7 IMM-124E Revenue Growth Rate (2015-2025)
11 Global Nonalcoholic Steatohepatitis (NASH) Market Segment by Application
    11.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application (2015-2020)
    11.2 Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application (2019-2024)
    11.3 Hospital Pharmacy Revenue Growth (2015-2020)
    11.4 Online Provider Revenue Growth (2015-2020)
    11.5 Retail Pharmacy Revenue Growth (2015-2020)
12 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2021-2025)
    12.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2021-2025)
    12.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Regions (2021-2025)
    12.3 North America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2021-2025)
    12.4 Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2021-2025)
    12.5 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2021-2025)
    12.6 South America Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2021-2025)
    12.7 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
    14.3 Disclaimer
    14.4 About US

Related Categories

Medical Devices

Get Custom Research at price of Syndicate

The report on the Global Digital Thermometers Market gives an estimation of the development of the market based on historical studies and also provides read more..

Global Nerve Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Nerve Monitoring Devices Market gives an estimation of the development of the market based on historical studies and also read more..

Global Air Filter Masks Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Air Filter Masks Market gives an estimation of the development of the market based on historical studies and also provides read more..

Global CT Machine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global CT Machine Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..

Global Bead Wire Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Bead Wire Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..

Global Nasopharyngoscope Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Nasopharyngoscope Market gives an estimation of the development of the market based on historical studies and also provides read more..

Global Digital Radiography Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Digital Radiography Systems Market gives an estimation of the development of the market based on historical studies and also read more..

Global Dental Extraction Forceps Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Dental Extraction Forceps Market gives an estimation of the development of the market based on historical studies and also read more..

Global Endoscopic Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Endoscopic Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..

Global Bronchoscope Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Bronchoscope Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..